We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Dr. Jörg Schickert

Partner
Munich

Dr. Jörg Schickert

If you work in the pharma, medical devices or biotech sector, it is Jörg Schickert who will be solving all your most complicated regulatory, commercial and compliance issues – for both Germany and all of Europe. His long-standing experience in dealing with German and European pharmaceutical and devices law means that he can circumspectly navigate you through all your reimbursement or pricing & reimbursement challenges. He will also aid you in drafting commercial/licensing contracts. Furthermore, you may turn to him with any most delicate criminal and compliance cases which your company might face. Jörg is very practical and always offers business-oriented solutions. He takes his industry knowledge from 15 years' experience in working hand-in-hand with many major and reputed life sciences companies.

Jörg is one of the few go-to lawyers in Europe for complex issues in the core business of the life sciences industry. He has a deep knowledge across all relevant legal areas of the day-to-day business of selling pharmaceutical products and devices or offering health solutions. This allows him to provide overall solutions for issues and projects which have implications in very different legal disciplines, such as regulatory, reimbursement, commercial, and compliance. He advises on reimbursement strategies, clinical trials, the launch and marketing of new products, dealing with healthcare professionals, anti-corruption/transparency, product safety and vigilance and related agreements and contracts. He also assists our corporate teams in transactions pertaining to the life science industry. Most recently, his life sciences industry team won the 'Life Sciences Practice of the Year' Award from JUVE, LMG and Best Lawyers – all in one year.

One client pinpoints his efforts to "really understand the client's needs" as a key strength, while another describes him as "particularly responsive and accountable."

Chambers Europe, 2016

Representative Experience

Advising a leading pharmaceutical company on its innovative approach regarding digital health offerings in 21 countries on 4 continents.

Advising a U.S. medical devices company on regulatory and commercial issues regarding the market launch of a gene test in 24 European countries.

Advising Baxter regarding the regulatory and commercial law aspects of the sale and transfer of its renal replacement business to Nikkiso in 29 countries.

Advising several pharmaceutical and medical devices companies on their HCP compliance under German anti-bribery laws.

Advising MorphoSys AG in drafting and negotiating a worldwide licence and collaboration agreement with Emergent Biosolutions re the joint development of an antibody.

Advising a leading U.S. biotech company on the HTA assessment before the German Federal Joint Committee (G-BA) and its strategy during price negotiations.

Education and admissions

Education

  • Second State Exam in Law, Higher Regional Court of Nuremberg, 2001
  • Dr. iur., FAU Erlangen-Nuremberg (Friedrich-Alexander-Universität), 2000
  • First State Exam in Law, FAU Erlangen-Nuremberg (Friedrich-Alexander-Universität), 1996

2015/2016

Recommended lawyer for pharmaceutical and medical device law

JUVE handbook

2015

Jörg Schickert has "very broad industry knowledge" and "is incredibly well versed in the EU law".

Legal 500 Germany

2017

Recommended as top lawyer for Health Care Law, Regulatory Practice and Pharmaceuticals Law

Best Lawyers Germany

2015

Jörg Schickert has been recognised as Life Sciences Europe Star for Regulatory and for Finance & Transactional

LMG Life Sciences

2016

Recommended lawyer for Regulatory – Life Sciences and Transactional – Life Sciences

Who's Who Legal

2016

Leading lawyer for legal regulation in the health sector

Legal 500 Germany

2014/2015

Clients praise the "very successful cooperation" with the team led by Dr. Jörg Schickert. They highlight in particular the "flexible and creative solutions".

JUVE handbook

2015

Recommended lawyer for Regulatory and for Financial & Transactional

LMG Life Sciences

Latest thinking and events

Published Works

Germany's benefit assessment for medicines already in the market – an uncertain look", Regulatory Affairs Journal – Pharma (October 2013)

Regulatory Affairs Journal – Pharma

Published Works

Early benefit assessment and price negotiations subject to AMNOG – risks for original companies through parallel import", PharmaR, book 4 (March 2013)

PharmaR
Loading data